Business · 07/05/2024Updated: 10/17/2026 · 1 min read
Fresenius Kabi USA, LLC, et. al.: FDA Withdraws Approval of 12 Abbreviated New Drug Applications
Summary
The US Food and Drug Administration (FDA) has withdrawn the approval of 12 abbreviated new drug applications (ANDAs) from multiple applicants, following written notifications that the drug products were no longer being marketed.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →